SCHEMBL4062974

SCHEMBL4062974

CC(C)(C)OC(=O)Oc1ccc(C2(c3ccc(O)cc3)c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 4/20 0.48
MAPT P10636 5/20 0.40
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
OPRK1 P41145 1/20 0.39
GPR55 Q9Y2T6 3/20 0.38
CNR1 P21554 2/20 0.38
PDK2 Q15119 3/20 0.38
KDM1A O60341 1/20 0.38
POLB P06746 1/20 0.37
CHRM2 P08172 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
KCNH2 Q12809 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30726805 0.95 ELANE (0.53) ELANEMAPTESR1ESR2KMT2A
SCHEMBL4063417 0.95 ELANE (0.53) ELANEMAPTESR1ESR2KMT2A
SCHEMBL25034220 0.84 ELANE (0.43) ELANEMAPTESR1ESR2KMT2A
SCHEMBL16882983 0.83 ELANE (0.42) ELANEMAPTESR1ESR2KMT2A
SCHEMBL11892504 0.83 ELANE (0.41) ELANEMAPTESR1ESR2KMT2A
SCHEMBL11892460 0.83 ELANE (0.41) ELANEMAPTESR1ESR2KMT2A
SCHEMBL13671582 0.82 MAPT (0.57) ELANEMAPTESR1ESR2KMT2A
SCHEMBL4853061 0.81 MAPT (0.45) ELANEMAPTESR1ESR2KMT2A
SCHEMBL11892477 0.81 ELANE (0.38) ELANEMAPTESR1ESR2PDK2
SCHEMBL18385988 0.81 ELANE (0.41) ELANEMAPTESR1ESR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM ELANE 422/4885MAPT 3954/4885ESR1 392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.